NOVARTIS AG-REG (NOT.DE) Stock Price, Quote, News and Overview

What is the stock price of NOVARTIS AG-REG today?

The current stock price of NOT.DE is 102.98 EUR. The price increased by 1.14% in the last trading session.

What is the ticker symbol for NOVARTIS AG-REG stock?

The exchange symbol of NOVARTIS AG-REG is NOT and it is listed on the Deutsche Boerse Ag exchange.

On which exchange is NOT.DE stock listed?

NOT.DE stock is listed on the Deutsche Boerse Ag exchange.

What is the price forecast or stock price prediction for NOVARTIS AG-REG stock?

32 analysts have analysed NOT.DE and the average price target is 111.96 EUR. This implies a price increase of 8.72% is expected in the next year compared to the current price of 102.98. Check the NOVARTIS AG-REG stock analysts ratings, price target forecast and up-and down grades for more detailed information.

What is NOVARTIS AG-REG worth?

NOVARTIS AG-REG (NOT.DE) has a market capitalization of 203.39B EUR. This makes NOT.DE a Mega Cap stock.

How many employees does NOVARTIS AG-REG have?

NOVARTIS AG-REG (NOT.DE) currently has 75883 employees.

What are the support and resistance levels for NOVARTIS AG-REG (NOT.DE) stock?

NOVARTIS AG-REG (NOT.DE) has a support level at 100.39 and a resistance level at 102.99. Check the full technical report for a detailed analysis of NOT.DE support and resistance levels.

Is NOVARTIS AG-REG (NOT.DE) expected to grow?

The Revenue of NOVARTIS AG-REG (NOT.DE) is expected to grow by 7.74% in the next year. Check the estimates tab for more information on the NOT.DE EPS, Sales, EBIT and EBITDA future analyst estimates.

Should I buy NOVARTIS AG-REG (NOT.DE) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:

• The Technical Analysis (TA) tab contains a technical analysis of NOT.DE, looking at technical quality and support and resistance levels
• The Fundamental Analysis (FA) tab contains a fundamental analysis of NOT.DE, evaluating the profitability, health, valuation and growth aspects
• NOVARTIS AG-REG (NOT.DE) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
• NOVARTIS AG-REG (NOT.DE) Sales and EPS estimates to see what analysts future expectations are.
• NOVARTIS AG-REG (NOT.DE) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
• NOVARTIS AG-REG (NOT.DE) Insider and Institutional Ownership to learn about the owners and their transactions.
• NOVARTIS AG-REG (NOT.DE) Stock Chart to make your own analysis
• NOVARTIS AG-REG (NOT.DE) Latest news and press-releases to stay up to date.

Does NOVARTIS AG-REG (NOT.DE) stock pay dividends?

NOVARTIS AG-REG (NOT.DE) has a dividend yield of 3.77%. The yearly dividend amount is currently 3.35. Check the full fundamental report for a detailed analysis of NOT.DE dividend history, reliability and sustainability.

When does NOVARTIS AG-REG (NOT.DE) report earnings?

NOVARTIS AG-REG (NOT.DE) will report earnings on 2025-07-17, before the market open.

What is the Price/Earnings (PE) ratio of NOVARTIS AG-REG (NOT.DE)?

The PE ratio for NOVARTIS AG-REG (NOT.DE) is 14.15. This is based on the reported non-GAAP earnings per share of 7.28 and the current share price of 102.98 EUR. Check the full fundamental report for a full analysis of the valuation metrics for NOT.DE.

ChartMill assigns a fundamental rating of 6 / 10 to NOT.DE. NOT.DE has an excellent profitability rating, but there are some minor concerns on its financial health.

Over the last trailing twelve months NOT.DE reported a non-GAAP Earnings per Share(EPS) of 7.28. The EPS increased by 18.6% compared to the year before.

ChartMill assigns a Buy % Consensus number of 68% to NOT.DE. The Buy consensus is the average rating of analysts ratings from 32 analysts.

For the next year, analysts expect an EPS growth of 11.31% and a revenue growth 7.74% for NOT.DE